4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000950170-24-132930
Chief Executive Officer sold 48,847 shares at $4.56 ($222,527)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tak Paul Peter Chief Executive Officer | 2024-11-29 | Sale | −48,847 | $4.56 | $222,527 | 294,788 | D |
| Open-market sales · 48,847 sh · avg $4.56 · $222,527 | |||||||
Loading xslF345X05/ownership.xml…